Inability to contact opioid agonist therapy prescribers during the COVID-19 pandemic in a Canadian setting: a cross-sectional analysis among people on opioid agonist therapy

BACKGROUND: The COVID-19 pandemic and consequent public health response may have undermined key responses to the protracted drug poisoning crisis, including reduced access to opioid agonist therapy (OAT) among people with opioid use disorder. Our study objectives were to estimate the prevalence of a...

Descripción completa

Detalles Bibliográficos
Autores principales: Moallef, Soroush, DeBeck, Kora, Fairbairn, Nadia, Cui, Zishan, Brar, Rupinder, Wilson, Dean, Johnson, Cheyenne, Milloy, M.-J., Hayashi, Kanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9751503/
https://www.ncbi.nlm.nih.gov/pubmed/36522789
http://dx.doi.org/10.1186/s13722-022-00354-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9751503/
https://www.ncbi.nlm.nih.gov/pubmed/36522789
http://dx.doi.org/10.1186/s13722-022-00354-x

Ejemplares similares